综合报道

川崎病与幼年特发性关节炎全身型合并巨噬细胞活化综合征临床特点对比分析

  • ZHOU Weiran ,
  • LIU Xuemei ,
  • DONG Linlin ,
  • et al
展开
  • 济南市儿童医院(山东济南 250022)

网络出版日期: 2020-10-10

基金资助

山东省重点研发计划(No.2017G00604)

Comparative analysis of clinical characteristics between Kawasaki disease and systemic macrophage activation syndrome and systematic-onset juvenile idiopathic arthritis

  • 周蔚然,刘雪梅,董琳琳,等
Expand
  • Jinan Children’s Hospital, Jinan 250022, Shandong, China

Online published: 2020-10-10

摘要

目的 对比川崎病(KD)与幼年特发性关节炎全身型(SJIA)合并巨噬细胞活化综合征(MAS)的临床特征。 方法 回顾性分析2015年9月至2019年9月收治的5例KD-MAS及8例SJIA-MAS患儿的临床资料。结果? KD-MAS患 儿均为男性,年龄5个月~7岁10个月;SJIA-MAS组8例共10次MAS过程,男性3例、女性5例,年龄1岁2个月~11岁,其 中男女各1例发生2次MAS,复发时年龄分别为6岁7个月、 8岁5个月。所有患儿均以持续高热为主要临床表现;实验室 指标比较,铁蛋白水平与LDH水平相关(P=0.03, r=0.071)。SJIA-MAS组铁蛋白中位数为14 900 ng/mL,LDH中位数为 1 264.5 U/L;KD-MAS组铁蛋白中位数为736 ng/mL,LDH中位数为492 U/L;两组比较差异有统计学意义(P<0.05)。KDMAS组中1例、SJIA-MAS组中3例行基因检测,未检出HLH相关基因。SJIA-MAS组8例患儿MAS过程中均给予甲基泼 尼松龙冲击加环孢素A治疗, 2例复发, 2例最终死亡。KD-MAS组患儿病初均给予2 g/kg免疫球蛋白治疗,诊断MAS后 1例给予甲基泼尼松龙冲击治疗, 1例给予甲基泼尼松龙冲击、环孢素及血浆置换治疗,其余3例给予甲基泼尼松龙7 mg/ (kg·d),后逐渐减量;所有患儿均能够有效控制病情。KD-MAS组中3例符合HLH-2004?诊断标准, 5例符合SJIA-MAS?2016 诊断标准。结论? LDH可能作为除铁蛋白外另一个早期识别MAS的敏感指标,KD-MAS与SJIA-MAS铁蛋白、LDH水平上 有差异,应用SJIA-MAS?2016诊断标准诊断KD-MAS的敏感性更高,KD-MAS治疗通过糖皮质激素即可达到较好疗效,且预 后较SJIA-MAS更好。

本文引用格式

ZHOU Weiran , LIU Xuemei , DONG Linlin , et al . 川崎病与幼年特发性关节炎全身型合并巨噬细胞活化综合征临床特点对比分析[J]. 临床儿科杂志, 2020 , 38(10) : 744 . DOI: 10.3969/j.issn.1000-3606.2020.10.006

Abstract

Objective? To?explore?the?comparison?of?the?clinical?features?between?Kawasaki?disease?(KD)?and?systematiconset?juvenile?idiopathic?arthritis?(SJIA)?with?macrophage?activation?syndrome?(MAS).?Method The clinical data of 5 cases of KD-MAS?and?8?cases?of?SJIA-MAS?children?admitted?from?September?2015?to?September?2019?were?retrospectively?analyzed.? Results? The?children?with?KD-MAS?were?all?male,?aged?from?5?months?to?7?years?and?10?months.?In?the?SJIA-MAS?group,?8? children?(3?boys?and?5?girls)?aged?from?1?year?and?2?months?to?11?years?had?10?times?of?MAS?in?total,?among?whom,?one?boy? and?one?girl?had?two?times?of?MAS?respectively,?and?the?age?at?recurrence?was?6?years?and?7?months,?and?8?years?and?5?months,? respectively.?The?main?clinical?manifestations?of?all?the?children?were?persistent?high?fever.?Comparison?of?laboratory?indicators? showed?that?ferritin?level?was?correlated?with?LDH?level?(r=0.071,?P=0.03).?The?median?ferritin?was?14900?ng/mL?and?the? median?LDH?was?1264.5?U/L?in?the?SJIA-MAS?group.?The?median?ferritin?and?LDH?in?the?KD-MAS?group?was?736?ng/ml?and? 492?U/L?respectively,?and?the?differences?between?the?two?groups?were?statistically?significant?(both?P<0.05).?One?case?in?the? KD-MAS?group?and?3?cases?in?the?SJIA-MAS?group?underwent?genetic?testing,?and?no?HLH-related?genes?were?detected.?The? condition?of?all?children?were?able?to?be?effectively?controlled.?Conclusion? LDH?may?serve?as?another?sensitive?indicator?for? early?identification?of?MAS?in?addition?to?ferritin.?There?are?differences?between?KD-MAS?and?SJIA-MAS?in?ferritin?and?LDH? levels.?The?application?of?SJIA-MAS?2016?diagnostic?criteria?to?diagnose?KD-MAS?is?more?sensitive.?KD-MAS?can?achieve? better?curative?effect?through?glucocorticoid?treatment,?and?the?prognosis?is?better?than?SJIA-MAS.
文章导航

/